| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | Kenny 5 | Genotype:cPLA2a-KI | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny 6 | Genotype:cPLA2a-KI | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny 7 | Genotype:cPLA2a-KI | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny 8 | Genotype:cPLA2a-KI | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny Eicosanoids 11 | Genotype:cPLA2a-KI | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny Eicosanoids 12 | Genotype:cPLA2a-KI | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny Eicosanoids 13 | Genotype:cPLA2a-KI | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny Eicosanoids 14 | Genotype:cPLA2a-KI | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny Eicosanoids 2 | Genotype:cPLA2a-KI | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny Eicosanoids 3 | Genotype:cPLA2a-KI | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny Eicosanoids 4 | Genotype:cPLA2a-KI | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny 10 | Genotype:cPLA2a-KO | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny 11 | Genotype:cPLA2a-KO | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny 12 | Genotype:cPLA2a-KO | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny 9 | Genotype:cPLA2a-KO | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny Eicosanoids 15 | Genotype:cPLA2a-KO | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny Eicosanoids 16 | Genotype:cPLA2a-KO | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny Eicosanoids 17 | Genotype:cPLA2a-KO | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny Eicosanoids 18 | Genotype:cPLA2a-KO | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny Eicosanoids 5 | Genotype:cPLA2a-KO | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny Eicosanoids 6 | Genotype:cPLA2a-KO | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny Eicosanoids 7 | Genotype:cPLA2a-KO | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny 1 | Genotype:Wild-type | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny 13 | Genotype:Wild-type | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny 14 | Genotype:Wild-type | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny 2 | Genotype:Wild-type | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny 3 | Genotype:Wild-type | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny 4 | Genotype:Wild-type | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny Eicosanoids 1 | Genotype:Wild-type | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny Eicosanoids 10 | Genotype:Wild-type | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny Eicosanoids 8 | Genotype:Wild-type | Treatment:NTEM | pmol/mL |
| Reversed phase NEGATIVE ION MODE | Kenny Eicosanoids 9 | Genotype:Wild-type | Treatment:NTEM | pmol/mL |
Return to study ST002445 main page
Download data matrix(The interaction of ceramide-1-phosphate with group IVA cytosolic phospholipase A2 modulates neutrophil polarization during inflammatory responses Reversed phase NEGATIVE ION MODE)
- Metabolomics Workbench
|